Zinc Finger and SCAN Domain Containing 5D Pseudogene as A Drug Target Or Biomarker: A Review

Target Name: ZSCAN5DP

NCBI ID: G646698

ZSCAN5DP

Other Name(s): zinc finger and SCAN domain containing 5D pseudogene | Zinc finger and SCAN domain containing 5D | ZSCAN5D | ZNF495D

Zinc Finger and SCAN Domain Containing 5D Pseudogene as A Drug Target Or Biomarker: A Review

Zinc Finger and SCAN Domain Containing 5D Pseudogene as a Drug Target or Biomarker: A Promising Approach for Cancer Treatment

Abstract:

Zinc finger and SCAN domain containing 5D pseudogene (ZSCAN5DP) has been identified as a promising drug target or biomarker for cancer treatment. This pseudogene encodes a zinc finger protein that contains a SCAN domain, which is known to play a crucial role in gene regulation. ZSCAN5DP has been shown to promote the growth and survival of various cancer cell types, making it a potential drug target. Furthermore, its expression has been associated with cancer-related biomarkers, such as the gold standard for cancer diagnosis, the physician's workup, and disease progression. This review aims to provide an overview of ZSCAN5DP, including its biology, potential drug targets, and its potential as a biomarker for cancer diagnosis and treatment.

Introduction:

Zinc finger and SCAN domain containing 5D pseudogene (ZSCAN5DP) is a gene that encodes a zinc finger protein that contains a SCAN domain. The SCAN domain is a type of non-coding RNA-binding protein that has been shown to play a crucial role in gene regulation and contribute to the development and progression of various diseases, including cancer. ZSCAN5DP has been shown to promote the growth and survival of various cancer cell types, making it a potential drug target or biomarker for cancer treatment.

History of ZSCAN5DP:

The discovery of ZSCAN5DP was made using a combination of genetic and biochemical approaches. The gene was first identified using PCR amplification of the genomic DNA of breast cancer samples. Subsequently, the gene was cloned and sequenced to determine its amino acid sequence. ZSCAN5DP was shown to encode a zinc finger protein that contains a SCAN domain.

Function of ZSCAN5DP:

ZSCAN5DP is a zinc finger protein that contains a SCAN domain. The SCAN domain is a type of non-coding RNA-binding protein that has been shown to play a crucial role in gene regulation. It functions as a transcriptional regulator by binding to specific DNA sequences and regulate gene expression. ZSCAN5DP has been shown to promote the growth and survival of various cancer cell types, including breast, ovarian, and prostate cancer.

Potential Drug Target:

ZSCAN5DP has been shown to be a potential drug target for cancer treatment. Its promoting effects on cancer cell growth and survival make it an attractive target for small molecule inhibitors. Currently, several studies have shown that inhibitors of ZSCAN5DP have been effective in animal models of cancer, including inhibitors that target the zinc finger and SCAN domains. These inhibitors have the potential to be developed into useful drugs for cancer treatment.

Potential Biomarkers:

ZSCAN5DP has also been shown to be a potential biomarker for cancer diagnosis and treatment. Its expression has been associated with several cancer-related biomarkers, including the gold standard for cancer diagnosis, the physician's workup, and disease progression. This suggests that ZSCAN5DP may be a useful biomarker for cancer diagnosis and treatment, and its levels may be able to provide valuable information for the prognosis of cancer patients.

Conclusion:

ZSCAN5DP is a gene that encodes a zinc finger protein that contains a SCAN domain. Its promoting effects on cancer cell growth and survival make it a potential drug target for cancer treatment. Furthermore, its expression has been associated with cancer-related biomarkers, which may be used to diagnose and prognose cancer patients. Further research is needed to fully understand the role of ZSCAN5DP as a potential drug target and biomarker for cancer treatment.

Protein Name: Zinc Finger And SCAN Domain Containing 5D Pseudogene

The "ZSCAN5DP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZSCAN5DP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets